Updated Evaluation of Dupilumab in the Treatment of Asthma: Patient Selection and Reported Outcomes
G Daniel Brooks The Asthma and Allergy Center, Bellevue, NE, USACorrespondence: G Daniel BrooksThe Asthma and Allergy Center, 3503 Samson Way, Suite 108, Bellevue, NE 68123, USATel +1-402-592-2055Fax +1-402-592-2419Email gdbrooks@asthmaandallergycenter.comAbstract: Uncontrolled asthma continues to b...
Guardado en:
Autor principal: | Brooks GD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/15454419d7904ee6b5f4dbc3c7fab253 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CRTH2 antagonists in asthma: current perspectives
por: Singh D, et al.
Publicado: (2017) -
Managing Exacerbations in Thunderstorm Asthma: Current Insights
por: Chatelier J, et al.
Publicado: (2021) -
Population pharmacokinetic analysis of dupilumab in adult and adolescent patients with asthma
por: Li Zhang, et al.
Publicado: (2021) -
A case of eosinophilic otitis media successfully treated by tympanoplasty with use of dupilumab
por: Saori Kikuchi, et al.
Publicado: (2021) -
Keratosis pilaris caused by dupilumab for the treatment of bronchial asthma
por: Yuka Shibata, et al.
Publicado: (2021)